BioSpace News Archive

BioMidwest

Spider Silk Production Breakthrough from Kraig Biocraft Laboratories

Innovation from Kraig Labs R&D Team delivers next generation Spider Silk

May 30, 2019
·
3 min read
Drug Development

F-star updates on FS118 Clinical Trial and Announces Presentation at ASCO 2019

F-star, a clinical-stage biopharmaceutical company delivering tetravalent bispecific antibodies for a paradigm-shift in cancer therapy, today provides a Phase 1 clinical update on its wholly-owned lead programme FS118 and announces a presentation at the ASCO Annual Meeting (Chicago, 01 June 2019).

May 30, 2019
·
4 min read
Deals

BiondVax Announces First Quarter 2019 Financial Results

BiondVax Pharmaceuticals Ltd. announced its financial results for the quarter ended March 31, 2019.

May 30, 2019
·
3 min read
Business

GT Biopharma GTB-1550 Clinical Development Update

T Biopharma, Inc. an immuno-oncology company focused on innovative treatments based on the Company’s proprietary NK cell engager (TriKE) platform and Multi-Target Directed Bispecific Drug Conjugate (MTBDC) platform, provided an update with respect to the further clinical development of GTB-1550.

May 30, 2019
·
8 min read
Pharm Country

Providing a Critical Roadmap to Bridge the Gap Between Medicine and Public Health

New Case Study from NYU School of Medicine Advances the Field of Population Health

May 30, 2019
·
4 min read
Genetown

KalVista Pharmaceuticals to Present at Jefferies Healthcare Conference - May 30, 2019

KalVista Pharmaceuticals, Inc. announced that it will present at the Jefferies Healthcare Conference on Thursday, June 6, 2019, at 4:00 p.m. ET in New York, NY.

May 30, 2019
·
2 min read
Sectra to Provide Large Centralized Regional Solution for Digital Pathology in the UK

International medical imaging IT and cybersecurity company Sectra has signed a five-year contract with North Tees and Hartlepool NHS Foundation Trust for the delivery of a regional digital pathology solution to the Northern Cancer Alliance.

May 30, 2019
·
4 min read
FDA

U.S. FDA Approves Supplemental New Drug Application Adding Overall Survival Data for XOSPATA® (gilteritinib)

Astellas Pharma Inc. announced that the U.S. Food and Drug Administration approved a supplemental New Drug Application to update the U.S. product labeling for XOSPATA® to include final analysis data from the ADMIRAL trial.

May 30, 2019
·
12 min read
Policy

Kroger Health Aims to Help Prevent Diabetes with Free Blood Glucose Screenings

According to the Centers for Disease Control and Prevention, over 84 million adults in the U.S. have prediabetes, yet the majority are unaware due to the lack of specific symptoms.

May 30, 2019
·
3 min read
Business

Vynca and Allegheny Health Network announce partnership to help honor patients’ end-of-life wishes

Allegheny Health Network announced a partnership with advance care planning technology provider, Vynca, to further assist patients and their families with end-of-life care decisions.

May 30, 2019
·
4 min read